Loading...
Proto Labs Inc (PRLB) is not a strong buy at this moment for a long-term beginner investor. While the company has shown positive revenue growth and a strong outlook for 2026, the recent financial performance highlights significant declines in net income and EPS, which may indicate underlying challenges. Additionally, the technical indicators suggest the stock is nearing resistance levels, and options data reflects limited bullish sentiment. Given the user's preference for long-term investment and the lack of strong proprietary trading signals, it would be prudent to hold off on buying at this time.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), and the MACD is positive but contracting, indicating a potential slowdown in upward momentum. RSI is neutral at 77.991. The stock is trading near its R1 resistance level of 66.719, with limited room for immediate upside.

Proto Labs reported record revenue of $136.5 million for Q4 2025, with full-year revenue reaching $533.1 million. The company has projected 6% to 8% growth for 2026, indicating a positive outlook.
Free cash flow also declined by 13%, raising concerns about profitability.
In Q4 2025, revenue increased by 12.11% YoY to $136.5 million, but net income dropped sharply to $6.0 million (-1584.90% YoY), and EPS fell to 0.25 (-1350.00% YoY). Gross margin improved slightly to 44.23%.
No recent analyst rating or price target changes were provided for PRLB.